Shankar Sharma warns CLSA"s Buy India note may mislead investors

Shankar Sharma has expressed doubts about CLSA"s recent "Buy India" note, suggesting that it may be a potential trap for retail investors and domestic institutions.

CLSA, a global brokerage firm, increased its allocation to India to a 20 percent overweight in November while reducing exposure to China.

Sharma questioned the motives behind this shift and speculated about a connection between CLSA and its Chinese parent company, CITIC Securities.

He referred to CLSA"s recommendation as a "Chinese-owned Trojan Horse" and accused the brokerage of misleading Indian investors by selling them unwanted products disguised as favorable advice.

This commentary highlights the ongoing division among brokerage houses regarding their outlook on Indian equities, as concerns about foreign influence and market manipulation persist.

Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings